© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
March 01, 2021
Investigators used MRI scans of the heart to identify whether heart injury was caused by COVID-19 infection.
February 23, 2021
New clinical practice guidelines call for lowering blood pressure levels down to 120 mmHg systolic for those with chronic kidney disease.
February 18, 2021
Once-weekly semaglutide 2.4 mg resulted in sustained reductions in weight for those who are overweight or obese, the investigators reported.
February 16, 2021
Novartis’ sacubitril/valsartan (Entresto) is now indicated for use in the treatment of chronic heart failure.
February 09, 2021
The American Heart Association’s recent scientific statement found that mental health impacts risk factors for heart disease.
Insulin resistance and type 2 diabetes were major contributors to premature coronary heart disease, according to the study results.
February 08, 2021
The American Heart Association (AHA) is urging those with heart conditions and those who are at risk for cardiovascular disease to receive the COVID-19 vaccine.
February 03, 2021
Pharmacists can help patients through education, therapy, and lifestyle modifications.
January 28, 2021
The latest Heart Disease and Stroke Statistical Update highlighted pandemic-related trends that may impact cardiovascular disease mortality for years.
A recent study examined patient characteristics and factors affecting COVID-19 mortality in individuals with diabetes.